Glenn Gregory M
Insider CIK 1342823 · NVAX SVP, Research and Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVAX NOVAVAX INC | M Exercise deriv | 2023-03-10 | 2023-03-14 | 6,298 | — | $0 | 12,596 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2023-03-10 | 2023-03-14 | 2,432 | $6.52 | $15.9K | 18,339 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2023-03-10 | 2023-03-14 | 1,000 | $6.50 | $6.5K | 14,473 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-03-10 | 2023-03-14 | 6,298 | $6.52 | $41.1K | 20,771 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2023-03-07 | 2023-03-14 | 2,000 | $7.04 | $14.1K | 13,473 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2023-03-06 | 2023-03-14 | 3,000 | $7.48 | $22.4K | 11,473 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-12-14 | 2022-12-16 | 3,100 | — | $0 | 3,100 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-12-14 | 2022-12-16 | 3,100 | — | $0 | 9,042 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2022-12-14 | 2022-12-16 | 1,033 | $17.23 | $17.8K | 8,009 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-03-10 | 2022-03-14 | 18,894 | — | $0 | 18,894 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-03-10 | 2022-03-14 | 28,341 | — | $0 | 28,341 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-12-15 | 2021-12-16 | 1,024 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-12-15 | 2021-12-16 | 662 | — | $0 | 7,944 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 213 | $170.46 | $36.3K | 7,019 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 206 | $179.58 | $37.0K | 5,690 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 103 | $178.99 | $18.4K | 5,896 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 223 | $176.83 | $39.4K | 5,999 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 67 | $175.89 | $11.8K | 6,222 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 137 | $174.65 | $23.9K | 6,289 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 91 | $173.29 | $15.8K | 6,426 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 27 | $180.62 | $4.9K | 5,663 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-12-15 | 2021-12-16 | 1,024 | $27.60 | $28.3K | 6,687 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-12-15 | 2021-12-16 | 662 | $46.00 | $30.5K | 7,349 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 117 | $168.82 | $19.8K | 7,232 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 254 | $171.47 | $43.6K | 6,765 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-15 | 2021-12-16 | 248 | $172.38 | $42.8K | 6,517 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-12-14 | 2021-12-16 | 3,100 | — | $0 | 6,200 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-12-14 | 2021-12-16 | 3,100 | — | $0 | 7,161 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2021-12-14 | 2021-12-16 | 1,498 | $168.43 | $252.3K | 5,663 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-12-07 | 2021-12-09 | 8,250 | — | $0 | 82,500 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 100 | $182.96 | $18.3K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 853 | $182.30 | $155.5K | 4,161 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-12-07 | 2021-12-09 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 500 | $180.29 | $90.1K | 5,014 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 500 | $179.36 | $89.7K | 5,514 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 500 | $178.21 | $89.1K | 6,014 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 800 | $176.20 | $141.0K | 6,514 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 900 | $175.13 | $157.6K | 7,314 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 200 | $173.14 | $34.6K | 8,214 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 200 | $171.30 | $34.3K | 8,414 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 400 | $168.77 | $67.5K | 8,614 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 300 | $167.06 | $50.1K | 9,014 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 300 | $165.80 | $49.7K | 9,314 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 300 | $164.77 | $49.4K | 9,614 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 200 | $162.83 | $32.6K | 9,914 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 300 | $161.63 | $48.5K | 10,114 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 300 | $160.52 | $48.2K | 10,414 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 300 | $158.42 | $47.5K | 10,714 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 200 | $157.02 | $31.4K | 11,014 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 300 | $156.24 | $46.9K | 11,214 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 100 | $154.38 | $15.4K | 11,514 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 397 | $153.53 | $61.0K | 11,614 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 100 | $151.85 | $15.2K | 12,011 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-12-07 | 2021-12-09 | 200 | $150.30 | $30.1K | 12,111 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-30 | 2021-12-02 | 8,250 | — | $0 | 90,750 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 353 | $207.19 | $73.1K | 7,041 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 439 | $206.06 | $90.5K | 7,394 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 465 | $203.79 | $94.8K | 7,833 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 715 | $202.37 | $144.7K | 8,298 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 338 | $201.23 | $68.0K | 9,013 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 717 | $200.40 | $143.7K | 9,351 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 678 | $199.25 | $135.1K | 10,068 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 836 | $198.17 | $165.7K | 10,746 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 100 | $211.75 | $21.2K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 518 | $195.87 | $101.5K | 11,938 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 200 | $194.62 | $38.9K | 12,456 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 222 | $192.58 | $42.8K | 12,656 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 4 | $191.29 | $765 | 12,878 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 121 | $189.98 | $23.0K | 12,882 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-30 | 2021-12-02 | 8,250 | $19.08 | $157.4K | 13,003 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 1,450 | $208.78 | $302.7K | 5,591 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 879 | $209.81 | $184.4K | 4,712 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 551 | $210.57 | $116.0K | 4,161 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-30 | 2021-12-02 | 356 | $197.31 | $70.2K | 11,582 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-26 | 2021-11-30 | 2,083 | — | $0 | 45,834 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-26 | 2021-11-30 | 1,377 | — | $0 | 30,296 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-26 | 2021-11-30 | 2,083 | $5.95 | $12.4K | 6,144 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-26 | 2021-11-30 | 185 | $215.00 | $39.8K | 5,959 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-26 | 2021-11-30 | 260 | $216.19 | $56.2K | 5,699 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2021-11-26 | 2021-11-30 | 647 | $217.97 | $141.0K | 4,753 | SEC↗ |
| NVAX NOVAVAX INC | D To issuer | 2021-11-26 | 2021-11-30 | 38 | $217.97 | $8.3K | 5,400 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-26 | 2021-11-30 | 1,377 | $5.95 | $8.2K | 5,438 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-26 | 2021-11-30 | 114 | $221.24 | $25.2K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-26 | 2021-11-30 | 155 | $220.22 | $34.1K | 4,175 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-26 | 2021-11-30 | 412 | $219.25 | $90.3K | 4,330 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-26 | 2021-11-30 | 626 | $218.25 | $136.6K | 4,742 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-26 | 2021-11-30 | 331 | $217.36 | $71.9K | 5,368 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-23 | 2021-11-24 | 8,250 | — | $0 | 99,000 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 1,400 | $197.44 | $276.4K | 10,111 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 800 | $196.43 | $157.1K | 11,511 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-23 | 2021-11-24 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 200 | $203.62 | $40.7K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 870 | $202.65 | $176.3K | 4,261 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 722 | $201.48 | $145.5K | 5,131 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 1,600 | $200.55 | $320.9K | 5,853 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 1,387 | $199.51 | $276.7K | 7,453 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-23 | 2021-11-24 | 1,271 | $198.47 | $252.3K | 8,840 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-16 | 2021-11-17 | 8,250 | — | $0 | 107,250 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-16 | 2021-11-17 | 600 | $170.94 | $102.6K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-16 | 2021-11-17 | 4,352 | $170.26 | $741.0K | 4,661 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-16 | 2021-11-17 | 1,326 | $168.91 | $224.0K | 9,013 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-16 | 2021-11-17 | 1,472 | $167.95 | $247.2K | 10,339 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-16 | 2021-11-17 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-16 | 2021-11-17 | 500 | $166.89 | $83.4K | 11,811 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-15 | 2021-11-17 | 662 | — | $0 | 8,606 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-15 | 2021-11-17 | 521 | — | $0 | 1,024 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-15 | 2021-11-17 | 521 | $27.60 | $14.4K | 4,582 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-15 | 2021-11-17 | 1,183 | $172.02 | $203.5K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-15 | 2021-11-17 | 662 | $46.00 | $30.5K | 5,244 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-09 | 2021-11-12 | 8,250 | — | $0 | 115,500 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-09 | 2021-11-12 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 400 | $170.55 | $68.2K | 4,161 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 100 | $171.48 | $17.1K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 1,478 | $169.54 | $250.6K | 4,561 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 672 | $168.46 | $113.2K | 6,039 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 2,000 | $167.76 | $335.5K | 6,711 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 1,800 | $166.55 | $299.8K | 8,711 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 1,400 | $165.72 | $232.0K | 10,511 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-09 | 2021-11-12 | 400 | $164.23 | $65.7K | 11,911 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-11-02 | 2021-11-04 | 8,250 | — | $0 | 123,750 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 300 | $187.26 | $56.2K | 5,839 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 500 | $186.09 | $93.0K | 6,139 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 302 | $184.82 | $55.8K | 6,639 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 800 | $183.58 | $146.9K | 6,941 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 600 | $182.58 | $109.5K | 7,741 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 670 | $181.55 | $121.6K | 8,341 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 600 | $180.41 | $108.2K | 9,011 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 900 | $179.09 | $161.2K | 9,611 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 1,200 | $178.12 | $213.7K | 10,511 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 600 | $177.12 | $106.3K | 11,711 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-11-02 | 2021-11-04 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 100 | $197.51 | $19.8K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 200 | $196.24 | $39.2K | 4,161 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 378 | $195.54 | $73.9K | 4,361 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 300 | $194.40 | $58.3K | 4,739 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 400 | $193.16 | $77.3K | 5,039 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 100 | $190.29 | $19.0K | 5,439 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-11-02 | 2021-11-04 | 300 | $188.33 | $56.5K | 5,539 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-29 | 2021-11-02 | 39 | $145.41 | $5.7K | 4,702 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-29 | 2021-11-02 | 26 | $152.16 | $4.0K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-29 | 2021-11-02 | 16 | $149.64 | $2.4K | 4,087 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-29 | 2021-11-02 | 108 | $146.51 | $15.8K | 4,594 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-29 | 2021-11-02 | 353 | $148.99 | $52.6K | 4,103 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-29 | 2021-11-02 | 138 | $148.08 | $20.4K | 4,456 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-26 | 2021-10-28 | 8,250 | — | $0 | 132,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-26 | 2021-10-28 | 2,084 | — | $0 | 47,917 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-26 | 2021-10-28 | 1,378 | — | $0 | 31,673 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-26 | 2021-10-28 | 2,084 | $5.95 | $12.4K | 6,145 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2021-10-26 | 2021-10-28 | 637 | $134.99 | $86.0K | 4,741 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-26 | 2021-10-28 | 1,500 | $130.93 | $196.4K | 12,895 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-26 | 2021-10-28 | 8,250 | $19.08 | $157.4K | 14,395 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-26 | 2021-10-28 | 3,000 | $131.91 | $395.7K | 9,895 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-26 | 2021-10-28 | 3,134 | $133.02 | $416.9K | 6,761 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-26 | 2021-10-28 | 1,700 | $133.82 | $227.5K | 5,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-26 | 2021-10-28 | 1,000 | $135.16 | $135.2K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-26 | 2021-10-28 | 1,378 | $5.95 | $8.2K | 5,439 | SEC↗ |
| NVAX NOVAVAX INC | D To issuer | 2021-10-26 | 2021-10-28 | 61 | $134.99 | $8.2K | 5,378 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-19 | 2021-10-21 | 8,250 | — | $0 | 140,250 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 100 | $172.03 | $17.2K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 800 | $168.49 | $134.8K | 4,861 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 1,366 | $167.08 | $228.2K | 5,661 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 1,000 | $165.98 | $166.0K | 7,027 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-19 | 2021-10-21 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 1,400 | $164.85 | $230.8K | 8,027 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 400 | $171.02 | $68.4K | 4,161 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 300 | $169.85 | $51.0K | 4,561 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 400 | $163.01 | $65.2K | 9,427 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 893 | $162.05 | $144.7K | 9,827 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-19 | 2021-10-21 | 1,591 | $161.00 | $256.2K | 10,720 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-15 | 2021-10-19 | 521 | — | $0 | 1,545 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-15 | 2021-10-19 | 662 | — | $0 | 9,268 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-15 | 2021-10-19 | 662 | $46.00 | $30.5K | 5,244 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-15 | 2021-10-19 | 521 | $27.60 | $14.4K | 4,582 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-15 | 2021-10-19 | 1,183 | $170.00 | $201.1K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-12 | 2021-10-14 | 8,250 | — | $0 | 148,500 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-12 | 2021-10-14 | 800 | $164.50 | $131.6K | 4,753 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-12 | 2021-10-14 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-12 | 2021-10-14 | 1,000 | $161.58 | $161.6K | 11,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-12 | 2021-10-14 | 2,900 | $162.45 | $471.1K | 8,411 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-12 | 2021-10-14 | 2,858 | $163.38 | $466.9K | 5,553 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-12 | 2021-10-14 | 392 | $165.70 | $65.0K | 4,361 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-12 | 2021-10-14 | 300 | $166.78 | $50.0K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-10-05 | 2021-10-07 | 8,250 | — | $0 | 156,750 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 700 | $172.70 | $120.9K | 7,940 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 2,200 | $171.86 | $378.1K | 8,640 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 1,471 | $170.80 | $251.2K | 10,840 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-10-05 | 2021-10-07 | 8,250 | $19.08 | $157.4K | 12,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 200 | $183.14 | $36.6K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 700 | $174.12 | $121.9K | 7,240 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 179 | $182.05 | $32.6K | 4,261 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 400 | $180.41 | $72.2K | 4,440 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 400 | $179.39 | $71.8K | 4,840 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 600 | $178.37 | $107.0K | 5,240 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 300 | $177.31 | $53.2K | 5,840 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 500 | $176.49 | $88.2K | 6,140 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-10-05 | 2021-10-07 | 600 | $175.32 | $105.2K | 6,640 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 55 | $203.94 | $11.2K | 4,648 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 51 | $202.84 | $10.3K | 4,703 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 280 | $207.01 | $58.0K | 4,352 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 16 | $211.39 | $3.4K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 40 | $210.16 | $8.4K | 4,077 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 118 | $209.27 | $24.7K | 4,117 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 117 | $207.99 | $24.3K | 4,235 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-30 | 2021-10-01 | 16 | $205.01 | $3.3K | 4,632 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-09-27 | 2021-09-29 | 2,083 | — | $0 | 50,001 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-09-27 | 2021-09-29 | 1,377 | — | $0 | 33,051 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 203 | $235.10 | $47.7K | 4,590 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-09-27 | 2021-09-29 | 2,083 | $5.95 | $12.4K | 6,144 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 57 | $228.12 | $13.0K | 6,087 | SEC↗ |
| NVAX NOVAVAX INC | D To issuer | 2021-09-27 | 2021-09-29 | 36 | $231.04 | $8.3K | 5,402 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-09-27 | 2021-09-29 | 1,377 | $5.95 | $8.2K | 5,438 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 95 | $248.13 | $23.6K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 56 | $243.98 | $13.7K | 4,156 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 99 | $240.37 | $23.8K | 4,212 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 124 | $239.04 | $29.6K | 4,311 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 57 | $237.29 | $13.5K | 4,435 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 98 | $236.30 | $23.2K | 4,492 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2021-09-27 | 2021-09-29 | 648 | $231.04 | $149.7K | 4,754 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 217 | $233.87 | $50.7K | 4,793 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 262 | $233.24 | $61.1K | 5,010 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 318 | $232.00 | $73.8K | 5,272 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 272 | $231.07 | $62.9K | 5,590 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-27 | 2021-09-29 | 225 | $229.99 | $51.7K | 5,862 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-09-15 | 2021-09-17 | 662 | — | $0 | 9,930 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-09-15 | 2021-09-17 | 521 | — | $0 | 2,066 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 65 | $233.02 | $15.1K | 4,106 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 165 | $232.01 | $38.3K | 4,171 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 196 | $231.08 | $45.3K | 4,336 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 45 | $234.73 | $10.6K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-09-15 | 2021-09-17 | 521 | $27.60 | $14.4K | 4,582 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 62 | $224.59 | $13.9K | 5,182 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 99 | $225.70 | $22.3K | 5,083 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 204 | $226.66 | $46.2K | 4,879 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 99 | $227.89 | $22.6K | 4,780 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 96 | $228.93 | $22.0K | 4,684 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-09-15 | 2021-09-17 | 152 | $230.10 | $35.0K | 4,532 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-09-15 | 2021-09-17 | 662 | $46.00 | $30.5K | 5,244 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 359 | $239.66 | $86.0K | 4,607 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 53 | $234.64 | $12.4K | 5,394 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 100 | $242.63 | $24.3K | 4,123 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 209 | $241.59 | $50.5K | 4,223 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 175 | $240.58 | $42.1K | 4,432 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 62 | $244.03 | $15.1K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 320 | $238.72 | $76.4K | 4,966 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-31 | 2021-09-01 | 108 | $237.14 | $25.6K | 5,286 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-08-26 | 2021-08-30 | 4,167 | — | $0 | 52,084 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-08-26 | 2021-08-30 | 2,754 | — | $0 | 34,428 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 100 | $227.74 | $22.8K | 8,128 | SEC↗ |
| NVAX NOVAVAX INC | D To issuer | 2021-08-26 | 2021-08-30 | 72 | $230.34 | $16.6K | 6,743 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-08-26 | 2021-08-30 | 2,754 | $5.95 | $16.4K | 6,815 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 100 | $241.57 | $24.2K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 100 | $240.04 | $24.0K | 4,161 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 346 | $238.62 | $82.6K | 4,261 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 400 | $237.35 | $94.9K | 4,607 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 200 | $236.13 | $47.2K | 5,007 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 400 | $235.27 | $94.1K | 5,207 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 616 | $233.89 | $144.1K | 5,607 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 700 | $232.89 | $163.0K | 6,223 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 400 | $231.35 | $92.5K | 6,923 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 605 | $230.52 | $139.5K | 7,323 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-26 | 2021-08-30 | 200 | $229.35 | $45.9K | 7,928 | SEC↗ |
| NVAX NOVAVAX INC | F Tax w/h | 2021-08-26 | 2021-08-30 | 1,296 | $230.34 | $298.5K | 5,447 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-08-26 | 2021-08-30 | 4,167 | $5.95 | $24.8K | 8,228 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-08-16 | 2021-08-18 | 1,322 | — | $0 | 10,592 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-08-16 | 2021-08-18 | 544 | — | $0 | 2,587 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 204 | $231.27 | $47.2K | 5,150 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 219 | $230.00 | $50.4K | 5,354 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 101 | $228.79 | $23.1K | 5,573 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 141 | $227.79 | $32.1K | 5,674 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 57 | $225.98 | $12.9K | 5,815 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 55 | $223.26 | $12.3K | 5,872 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-08-16 | 2021-08-18 | 1,322 | $46.00 | $60.8K | 5,927 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-08-16 | 2021-08-18 | 544 | $27.60 | $15.0K | 4,605 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 274 | $232.15 | $63.6K | 4,876 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 13 | $234.88 | $3.1K | 4,533 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 177 | $234.38 | $41.5K | 4,546 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 153 | $233.17 | $35.7K | 4,723 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 14 | $248.98 | $3.5K | 4,061 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 51 | $246.72 | $12.6K | 4,075 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 50 | $244.99 | $12.2K | 4,126 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 107 | $242.99 | $26.0K | 4,176 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 78 | $240.37 | $18.7K | 4,283 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 61 | $239.32 | $14.6K | 4,361 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 63 | $237.92 | $15.0K | 4,422 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-08-16 | 2021-08-18 | 48 | $236.22 | $11.3K | 4,485 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 199 | $202.76 | $40.3K | 4,902 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 119 | $200.61 | $23.9K | 5,101 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 56 | $229.44 | $12.8K | 2,811 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 189 | $228.60 | $43.2K | 2,867 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 306 | $227.17 | $69.5K | 3,056 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 173 | $225.91 | $39.1K | 3,362 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 63 | $224.33 | $14.1K | 3,535 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 240 | $220.66 | $53.0K | 3,598 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 56 | $218.69 | $12.2K | 3,838 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 56 | $217.44 | $12.2K | 3,894 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 126 | $214.76 | $27.1K | 3,950 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 141 | $213.55 | $30.1K | 4,076 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 63 | $211.93 | $13.4K | 4,217 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 126 | $207.63 | $26.2K | 4,280 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2021-07-20 | 2021-07-22 | 135 | $206.82 | $27.9K | 4,406 | SEC↗ |